Security key
19249H103
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)
CUSIP: 19249H103
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 153,624,096
- Total 13F shares
- 77,664,501
- Share change
- -1,915,172
- Total reported value
- $746,258,214
- Price per share
- $9.61
- Number of holders
- 168
- Value change
- -$14,908,210
- Number of buys
- 83
- Number of sells
- 83
Report period
Q3 2022
Institutions
168
Top holders
10
CHRS full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Coherus Oncology, Inc. SEC filings
Coherus Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19249H103
Recent filing periods:
Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.4%
|
12,883,490
|
$93,277,000 | — | 30 Jun 2022 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
4.8%
|
7,381,116
|
$53,439,280 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.2%
|
6,486,231
|
$46,959,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
6,383,103
|
$46,214,000 | — | 30 Jun 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.7%
|
5,675,449
|
$41,090,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
4,883,415
|
$35,355,000 | — | 30 Jun 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.4%
|
3,645,471
|
$26,393,000 | — | 30 Jun 2022 | |
| Kohlberg Kravis Roberts & Co. L.P. |
13F
|
Company |
2%
|
3,036,076
|
$22,644,000 | — | 30 Jun 2022 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
1.5%
|
2,322,168
|
$16,812,000 | — | 30 Jun 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
1,944,003
|
$14,074,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
1,196,852
|
$8,665,000 | — | 30 Jun 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.7%
|
1,078,109
|
$7,806,000 | — | 30 Jun 2022 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.7%
|
1,077,285
|
$7,800,000 | — | 30 Jun 2022 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.6%
|
928,464
|
$6,722,000 | — | 30 Jun 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.58%
|
888,584
|
$6,433,000 | — | 30 Jun 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.58%
|
887,585
|
$6,426,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
813,136
|
$5,888,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.5%
|
769,681
|
$5,572,000 | — | 30 Jun 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
750,000
|
$5,430,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.49%
|
746,844
|
$5,407,000 | — | 30 Jun 2022 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.45%
|
688,326
|
$4,983,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.44%
|
680,633
|
$4,927,000 | — | 30 Jun 2022 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.43%
|
662,087
|
$4,794,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
600,975
|
$4,351,000 | — | 30 Jun 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.39%
|
598,304
|
$4,332,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.38%
|
579,311
|
$4,194,000 | — | 30 Jun 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.36%
|
546,665
|
$3,958,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
475,997
|
$3,447,000 | — | 30 Jun 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.31%
|
470,805
|
$3,409,000 | — | 30 Jun 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.28%
|
431,375
|
$3,123,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
389,305
|
$2,819,000 | — | 30 Jun 2022 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.25%
|
388,047
|
$2,775,000 | — | 30 Jun 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
0.25%
|
376,486
|
$2,726,000 | — | 30 Jun 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.22%
|
332,784
|
$2,409,000 | — | 30 Jun 2022 | |
| Phocas Financial Corp. |
13F
|
Company |
0.21%
|
316,455
|
$2,291,000 | — | 30 Jun 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.2%
|
301,589
|
$2,184,000 | — | 30 Jun 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.16%
|
253,237
|
$1,833,000 | — | 30 Jun 2022 | |
| DISCIPLINED GROWTH INVESTORS INC /MN |
13F
|
Company |
0.16%
|
246,021
|
$1,781,000 | — | 30 Jun 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.15%
|
230,106
|
$1,666,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.14%
|
212,626
|
$1,539,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
205,500
|
$1,488,000 | — | 30 Jun 2022 | |
| CM Management, LLC |
13F
|
Company |
0.13%
|
200,000
|
$1,448,000 | — | 30 Jun 2022 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.13%
|
195,421
|
$1,414,000 | — | 30 Jun 2022 | |
| David M. Knott Jr. |
13F
|
Individual |
0.12%
|
186,134
|
$1,348,000 | — | 30 Jun 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
180,303
|
$1,305,000 | — | 30 Jun 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.12%
|
179,800
|
$1,302,000 | — | 30 Jun 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.11%
|
175,090
|
$1,268,000 | — | 30 Jun 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.11%
|
167,828
|
$1,215,000 | — | 30 Jun 2022 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.11%
|
162,146
|
$1,174,000 | — | 30 Jun 2022 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.1%
|
155,000
|
$1,122,000 | — | 30 Jun 2022 |
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2022
As of 30 Sep 2022,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
77,664,501 shares.
The largest 10 holders included
BlackRock Inc., Temasek Holdings (Private) Ltd, JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, STATE STREET CORP, Kohlberg Kravis Roberts & Co. L.P., Aristotle Capital Boston, LLC, AMERIPRISE FINANCIAL INC, and PERCEPTIVE ADVISORS LLC.
This page lists
168
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
171
Q3 2022 holders
168
Holder diff
-3
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.